Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth

Journal of Immunology

Volumn 192, Issue 7, 2014, Pages 2939-2952

  Kehrl, John H ^a   Wakefield, Lalage M ^b   Roberts, Anita B ^b   Jakowlew, Sonia ^b   Alvarez Mon, Melchor ^c   Derynck, Rik ^d   Sporn, Michael B ^b   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 2; MESSENGER RNA; MYC PROTEIN; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL CYCLE REGULATION; CELL STIMULATION; CELL TYPE; COLONY FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; REGULATORY MECHANISM; T LYMPHOCYTE; UPREGULATION; CELL PROLIFERATION; HISTORY; IMMUNOLOGY; METABOLISM;

CELL PROLIFERATION; HISTORY, 20TH CENTURY; HUMANS; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84897564574     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Roberts, A. B., C. A. Frolik, M. A. Anzano, and M. B. Sporn. 1983. Transforming growth factors from neoplastic and nonneoplastic tissues. Fed. Proc. 42:2621.
2. Anzano, M. A., A. B. Roberts, J. M. Smith, M. B. Sporn, and J. E. DeLarco. 1983. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type a and type β transforming growth factors. Proc. Natl. Acad. Sci. USA. 80:6264.
3. Assoian, R. K., A. Komoriya, C. A. Meyers, and M. B. Sporn. 1983. Transforming growth factor-β in human platelets: identification of a major storage site, purification, and characterization.. Biol. Chem. 258:7155.
4. Frolik, C. A., L. L. Dar, C. A. Meyers, D. M. Smith, and M. B. Sporn. 1983. Purification and initial characterization of a type β transforming growth factor from human placenta. Proc. Natl. Acad. Sci. USA. 80:3676.
5. Roberts, A., M. Anzano, C. Meyers, J. Wideman, R. Blacher, Y. E. Pan, S. Stein, S. R. Lehrman, J. M. Smith, L. C. Lamb, and M. B. Sporn. 1983. Purification and properties of a type β transforming growth factor from bovine kidney. Biochemistry. 22:5692.
6. Childs, C. B., J. A. Proper, R. F. Tucker, and H. L. Moses. 1982. Serum contains a platelet-derived transforming growth factor. Proc. Natl. Acad. Sci. USA. 79:5312.
7. Derynck, R., J. A. Jarret, E. Y. Chen, D. H. Eaton, J. R. Bell, R. K. Assoian, A. B. Roberts, M. B. Sporn, and D. V. Goeddel. 1985. Human transforming growth factor-complementary DNA sequence and expression in normal and transformed cells. Nature (Lond.). 316:701.
8. Frolik, C. A., L. M. Wakefield, D. M. Smith, and M. B. Sporn. 1984. Characterization of a membrane receptor for transforming growth factor-β in normal rat kidney fibroblasts. Biol. Chem. 259:10995.
9. Tucker, R. F., E. L. Branum, G. D. Shipley, R.J. Ryan, and H. L. Moses. 1984. Specific binding to cultured cells of 125I-labeled type β transforming growth factor from human platelets. Proc. Natl. Acad. Sci. USA. 81:6757.
10. Roberts, A. B., M. A. Anzano, L. C. Lamb, J. M. Smith, and M. B. Sporn. 1981. New class of transforming growth factors potentiated by epidermal growth factor: Isolation from non-neoplastic tissues. Proc. Natl, Acad. Sci. USA. 78:5339.
11. Assoian, R. K., C. A. Frolik, A. B. Roberts, D. M. Miller, and M. B. Sporn. 1984. Transforming growth factor-β controls. Receptor levels for epidermal growth factor in NRK fibroblasts. Cell. 36:35.
12. Roberts, A. B., M. A. Anzano, L. M. Wakefield, N. E. Roche, D. F. Stern, and M. B. Sporn. 1985. Type β transforming growth factor. A bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA. 82:119.
13. Tucker, R. F., G. D. Shipley, H. L. Moses, and R. W. Holley. 1984. Growth inhibitor from BSC-1 cells closely related to platelet Type β transforming growth factor. Science (Wash. DC). 226:705.
14. Smith, K. A. 1984. Lymphokine regulation of T cell and B cell function. In Fundamental Immunology. W. E. Paul, editor. Raven Press, New York. pp. 559.
15. Falkoff, R.J. M., L. P. Zhu, and A. S. Fauci. 1982. Separate signals for human B cell proliferation and differentiation in response to Staphylococcus aureus: evidence for a two-signal model of B cell activation.. J. Immunol. 129:97.
16. Rosenberg, S., E. Grimm, M. McGrogan, M. Doyle, E, Kawasaki, K. Koths, and D. Mark. 1984. Biological activity of recombinant interleukin-2 produced by Escherichia coli Science (Wash. DC). 223:1412.
17. Larsson, E.-L., and A. Coutinho. 1979. The role of mitogenic lectins in T cell triggering. Nature (Lond.) 280:239.
18. Larsson, E.-L. 1981. Mechanisms of T cell activation. II. Antigen- and lectin-dependent acquisition of responsiveness to TCGF is a non-mitogenic, active response of resting T cells. J. Immunol. 126:1323.
19. Meuer, S. C, R. E. Hussey, D. A. Cantrell, J. C. Hodgdon, S. F. Schlossman, K. A. Smith, and E. L. Reinhert. 1984. Triggering of the T3-T1 antigen receptor complex results in clonal T cell proliferation through an interleukin-2 dependent autocrine pathway. Proc. Natl. Acad. Sci. USA. 81:1509.
20. Reem, G. H., and N.-H. Yeh. 1984. Interleukin-2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes. Science (Wash. DC). 225:429.
21. Welte, K., M. Andreff, E. Platzer, K. Holloway, B. Y. Rubin, M. A. S. Moore, and R. Mertelsmann. 1984. Interleukin-2 regulates the expression of Tac antigen on peripheral blood T lymphocytes. J. Exp. Med. 160:1390.
22. Sutherland, R., D. Delia, C. Schneider, R. Newman, J. Kemshead, and M. Greaves. 1981. Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc. Natl. Acad. Sci. USA. 78:4515.
23. Dillner-Centerlind, M.-L., S. Hammarstrom, and P. Perlmann. 1979. Transferrin can replace serum for in vitro growth of mitogen-stimulated T lymphocytes. Eur. J. Immunol. 9:942.
24. Trowbridge, I. S., and F. Lopez. 1982. Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro. Proc. Natl. Acad. Sci. USA. 79:1175.
25. Rosenthal, A. S., and E. M. Shevach. 1973. Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes. J. Exp. Med. 138:1194.
26. Katz, D. H., and B. Bennacerraf. 1975. The function and interrelationship of T cell receptors, Ir genes, and other histocompatibility gene products. Transplant. Rev. 22:175.
27. Davis, M. D., Y. Chien, N. R.J. Gascoigne, and S. M. Hedrick. 1984. A murine T cell receptor gene complex: Isolation structure and rearrangement. Immunol. Rev. 81:235.
28. Smith, K. A. 1980. T-cell growth factor. Immunol. Rev. 51:337.
29. Robb, R. J., A. Munck, and K. A. Smith. 1981. T-cell growth factor receptors: quantitation, specificity, and biological relevance. J. Exp. Med. 154:1455.
30. Smith, K. A., and D. A. Cantrell. 1985. Interleukin-2 regulates its own receptors. Proc. Natl. Acad. Sci. USA. 82:864.
31. Depper, J. M., W.J. Leonard, C. Drogula, M. Kronke, T. A. Waldmann, and W. C. Greene. 1985. Interleukin-2 (IL-2) augments transcription of the IL-2 receptor gene. Proc. Natl. Acad. Sci. USA. 82:4230.
32. Cantrell, D. A., and K. A. Smith. 1983. Transient expression of IL-2 receptors. Consequences for T cell growth. J. Exp. Med. 158:1895.
33. Kryceve-Martinerie, C, D. A. Lawrence, J. Crochet, P. Jullien, and P. Vigier. 1985. Further study of 0-TGF released by virally transformed and non-transformed cells. Int. J. Cancer. 35:553.
34. Holley, R. W., R. Armour, and J. H. Baldwin. 1978. Density-dependent regulation of growth of BSC-1 cells in cell culture: growth inhibitors formed by these cells. Proc. Natl. Acad. Sci. USA. 75:1864.
35. Sporn, M. B., A. B. Roberts, J. H. Shull, J. M. Smith, J. M. Ward, and J. Sodek. 1983. Polypeptide transforming growth factors isolated from bovine sources used for wound healing in vivo. Science (Wash. DC). 219:1329.
36. Ross, R. 1968. Wound healing. Biol. Rev. 43:51.
37. Postlethwaite, A. R., G. N. Smith, C. L. Mainardi, J. M. Seyer, and A. H. Kang. 1984. Lymphocyte modulation of fibroblast function in vitro: Stimulation and inhibition of collagen production by different effector molecules. J. Immunol. 132:2470.
38. Roberts, A. B., M. B. Sporn, R. K. Assoian, J. M. Smith,, N. S. Roche, L. M. Wakefield, U. I. Heine, L. A. Liotta, V. Falanga, J. H. Kehrl, and A. S. Fauci. 1986. Transforming growth factor-beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl Acad. Sci. USA. In press.
39. Rook. A. H., J. H. Kehrl, L. M. Wakefield, A. B. Roberts, D. B. Burlington, H. C. Lane, and A. S. Fauci. 1986. Effects of transforming growth factor β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol. In press.